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Abstract
This observational study aimed to describe immunopathogenesis and treatment outcomes in children with and
without severe acute malnutrition (SAM) and HIV-infection. We studied markers of microbial translocation
(16sDNA), intestinal damage (iFABP), monocyte activation (sCD14), T-cell activation (CD38, HLA-DR) and
immune exhaustion (PD1) in 32 HIV-infected children with and 41 HIV-infected children without SAM prior to
initiation of antiretroviral therapy (ART) and cross-sectionally compared these children to 15 HIV-uninfected
children with and 19 HIV-uninfected children without SAM. We then prospectively measured these markers
and correlated them to treatment outcomes in the HIV-infected children at 48 weeks following initiation of
ART. Plasma levels of 16sDNA, iFABP and sCD14 were measured by quantitative real time PCR, ELISA and
Luminex, respectively. T cell phenotype markers were measured by flow cytometry. Multiple regression
analysis was performed using generalized linear models (GLMs) and the least absolute shrinkage and selection
operator (LASSO) approach for variable selection. Microbial translocation, T cell activation and exhaustion
were increased in HIV-uninfected children with SAM compared to HIV-uninfected children without SAM. In
HIV-infected children microbial translocation, immune activation, and exhaustion was strongly increased but
did not differ by SAM-status. SAM was associated with increased mortality rates early after ART initiation.
Malnutrition, age, microbial translocation, monocyte, and CD8 T cell activation were independently associated
with decreased rates of CD4% immune recovery after 48 weeks of ART. SAM is associated with increased
microbial translocation, immune activation, and immune exhaustion in HIV-uninfected children and with worse
prognosis and impaired immune recovery in HIV-infected children on ART.
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Introduction
Malnutrition was estimated to be the underlyingcause for 45% of deaths in children less than 5 years of
age in 2011 globally.1 The prevalence of malnutrition in HIV-
infected children is as high as 40%, making clinical manage-
ment of this vulnerable population even more challenging.2,3
Co-occurrence of severe acute malnutrition (SAM) and HIV
results in increased morbidity and mortality largely due to
increased incidence and severity of concurrent infections.4–6
Immunological alterations such as systemic inflammation and
impaired cellular immune responses have been attributed to
malnutrition7 that could explain this increased susceptibility to
infection especially when exacerbated by HIV infection, but
the underlying mechanisms remain largely unresolved.
Malnutrition is characterized by functional and structural
alterations in the intestinal mucosa associated with chronic
intestinal inflammation.8 Direct effects of malnutrition9 and
perturbations in the gut microbiome10 that are only partially
restored after nutritional interventions11,12 have been proposed
as a primary cause for persistent intestinal inflammation and
epithelial damage. In HIV infection breakdown of the intestinal
barrier, depletion of gut-resident CD4+ T cell populations and
mucosal immune dysregulation results in microbial transloca-
tion that drives systemic immune activation.13 Chronic immune
activation is a hallmark of disease progression in HIV-infected
children and results in accelerated loss of CD4 T cells, immune
dysregulation, and immune exhaustion.14
In HIV-infected children, it is not known whether SAM is
associated with increased microbial translocation, immune ac-
tivation, and immune exhaustion and whether this is modulated
byART.We sought to describe and compare levels ofmicrobial
translocation and immune activation and exhaustion in HIV-
uninfected and HIV-infected ART-naive children presenting
with or without SAM and after 48 weeks of ART. We hy-
pothesize that (i) malnutrition is associated with microbial
translocation, immune activation, and immune exhaustion in
HIV-infected and uninfected children; (ii) malnutrition, micro-
bial translocation, and immune activation are associated with
detrimental treatment outcome in HIV-infected children on
ART. The current knowledge of microbial translocation and
immunopathogenesis in the context of SAM andHIV is limited.
Findings from this study may help to inform about the patho-
genesis of malnutrition and HIV infection and guide additional
interventions in the management of this critically ill population.
Materials and Methods
Study subjects and procedures
We studied four different groups of children aged 2months
to 12 years with the following inclusion criteria: (i) HIV+
SAM+: Presentingwith SAM, confirmedHIV infection, ART-
naive; (ii) HIV+SAM-: No SAM, confirmed HIV infection,
ART-naive; (iii) HIV-SAM+: Presence of SAM, confirmed
negative HIV status; and (iv) HIV-SAM-: No SAM, con-
firmed negative HIV status, absence of severe acute or chronic
medical disease. Exclusion criteria for all groups were lack of
consent/assent or previous admission for SAM.
HIV+SAM+ (n = 32) children were recruited as part of the
recently described MATCH cohort15 (Clinical trial registry
number: PACTR 21609001751384) from the pediatric ward
of the King Edward VIII Hospital, Durban, South Africa,
between July 2012 and March 2015. All other groups were
recruited independent of the MATCH cohort between March
2013 and June 2014. HIV+SAM- children were recruited
from the pediatric wards and outpatient clinic at the King
Edward VIII Hospital (n = 20) and from the outpatient clinic
at the Ithembalabantu Clinic, Umlazi, Durban, South Africa
(n= 21). HIV-SAM+ (n = 15) children were recruited from
the pediatric wards of the King Edward VIII Hospital. HIV-
uninfected siblings of HIV+SAM- children (n= 19) were
recruited as HIV-SAM- group. Numbers of subjects at
each stage of the study are summarized in Supplementary
Figure S1 (Supplementary Data are available online at www
.liebertpub.com/aid). All study participants were black Af-
rican children mainly of Zulu and Xhosa origin.
HIV status was diagnosed as per the South African National
HIV Treatment Guidelines16 by two independent ELISA/
Western blot assays in children above 18months of age and two
DNA PCR assays (TaqMan HIV-1 Qualitative Test; Roche
Molecular Systems, Inc.) in children under 18 months by the
National Health Laboratory Service (NHLS), South Africa.
SAM was defined based on 2009 WHO criteria17 as
presence of: (i) weight-for-height more than three SD below
the mean, (ii) mid-upper arm circumference <115mm, or (iii)
the presence of bilateral lower extremity pitting edema of
nutritional origin. The WHO Anthro software package 3.2.2
for SPSS was used to calculate anthropometric z-scores. All
children with SAM were admitted and managed based on the
WHO guidelines for the in-patient treatment of severely
malnourished children with standardized refeeding guide-
lines.17 Children were only discharged once they had reached
nutritional recovery as defined in these guidelines. All chil-
dren with SAM received antibiotics (Penicillin and Genta-
micin) and antihelminthics (albendazole). HIV+SAM+
children additionally received Cotrimoxazole prophylaxis.
All HIV-infected children were initiated on ART according
to the current South African guidelines16 using a combination
of abacavir and lamivudine plus either efavirenz or ritonavir
boosted lopinavir. HIV+SAM+ children were initiated on
ART after a median time of 11 days following hospitaliza-
tion. Baseline blood samples were taken on the same day
before the first dose of ARTwas given. HIV-positive children
with SAM were followed up at week 4, 8, 12, 24, and 48 and
without SAM at week 12, 24, and 48 only. All children were
screened for active tuberculosis disease and if indicated
treated according to national guidelines.
All research blood samples were collected in Ethylenedia-
minetetraacetic acid tubes and processed within 6 h after veni-
puncture at the HIV Pathogenesis Programme (HPP), UKZN,
Durban, South Africa. Plasma was separated by centrifugation
and cryopreserved at -80C. Peripheral blood mononuclear
cells (PBMCs) were isolated by Ficoll density gradient centri-
fugation and used for flow cytometric analysis immediately.
Written informed consent was obtained from caregivers
for all study participants and, in addition, assent to participate
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in the study was given directly by children in the appropriate
age groups. The study was reviewed and approved by the
University of KwaZulu-Natal Ethics Review Board, Co-
lumbia University Institutional Review Board, and the Ox-
ford Research Ethics Committee.
CD4 count and viral load measurements
Viral load levels were determined by the NHLS using the
COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0 by
Roche.18 CD4+ T cell counts and percentage were measured
by the NHLS using flow cytometry.
Quantification of plasma biomarkers
Plasma levels of sCD14 were quantified using a Luminex Kit
(R&D systems, Minneapolis, MN) at a 100-fold dilution in du-
plicate as per manufacturer’s recommendations on a calibrated
Luminex 200 analyzer (Luminex Corporation, Austin, TX).
Plasma concentrations of intestinal fatty acid-binding protein
(iFABP) were quantified using an ELISA Kit (R&D systems,
Minneapolis,MN) in duplicate at a 1:10 dilution according to the
manufacturer’s instructions. Results were expressed in pg/ml.
Real-time PCR quantitation of 16S rDNA in plasma
To minimize the risk of contamination, blood samples were
obtained using standard aseptic techniques following cleansing
of the skin with 2% chlorhexidine/alcohol solution. Subse-
quently, all sampleswere handled in laminar flowcabinets under
sterile conditions. Total DNA was extracted from 200ll cryo-
preserved plasma using the column-based QIAamp DNA Mini
Kit (Qiagen). 16S rDNA was amplified using the following
published primers19: 5¢- AGAGTTTGATCCTGGCTCAG -3¢
(forward) and 5¢- CTGCTGCCTCCCGTAGGAGT - 3¢ (re-
verse). Each PCR comprised 3.5mmol/llMgCl2, 0.125 pmol/ll
of each primer, 5ll of SYBRGreen IMasterMix (2X) (Roche),
2ll of DNA, and water to 10ll. Reactions were run in triplicate
on a Roche LightCycler 480 version 1.5 as follows: 1 cycle at
95C for 10min, followed by 45 cycles at 95C for 30 s, at 60C
for 30 s, and at 72C for 30 s. A standard curvewas created from
serial dilutions of DH5a bacterial DNA containing known copy
numbers of the template calculated by molecular weight as de-
scribed previously.20 Individual samples were then analyzed
against the standard curve, and 16S rDNA copy numbers per
microliter of plasma were calculated.
Surface phenotypic staining and flow cytometry
PBMCs were used for stainingwith fluorochrome-conjugated
monoclonal antibodies against cell surface markers for T cell
activation, exhaustion, and memory differentiation as de-
scribed previously.21 Briefly, freshly isolated PBMCs were
washed in phosphate buffered saline, adjusted to two million
cells per stain, and incubated with titrated concentrations of
the following antibodies in a staining volume of 50lL in PBS:
1:100 CD3/BV605 (SK7; BD Biosciences), 1:100 CD4/V450
(RPA-T4; BD Biosciences), 1:100 CD8/V500 (RPA-T8; BD
Biosciences), 1:50 PD-1/APC (MIH4; eBioscience), 1:25
CCR7/PE (150503; R&D Systems), 1:50 CD45RA/Alexa
Fluor 700 (HI100; BioLegend), 1:25 HLA-DR/FITC (L243;
BD Biosciences), and 1:25 CD38/PE-Cy7 (HIT2; BD Bios-
ciences). After 20min incubation at room temperature cells
were washed twice in PBS and resuspended in PBS with 2%
paraformaldehyde. Near-infrared LIVE/DEAD marker (In-
vitrogen) was used to exclude nonviable cells. Fluorescence
minus one staining was used to determine the cutoff for PD1
high cells. Data were acquired on a LSR-II driven by
FACSDiva software (BD) and analyzed using FlowJo soft-
ware v8.8.6 (TreeStar, Ashland,OR).All FACSanalyseswere
performed using freshly isolated PBMCs at the HIV Patho-
genesis Programme, UKZN, Durban, South Africa.
Statistical analyses
Due to missing samples and incomplete clinical records, the
dataset was incomplete. All available data are presented indi-
cating the sample size for each parameter and group. Baseline
characteristics were compared between study groups using
Kruskal–Wallis ANOVA with Dunn’s correction for multiple
comparisons. Spearman correlations were used to explore bi-
variate associations. Kaplan–Meier survival curves were com-
pared by the log-rank (Mantel–Cox) test. Statistical significance
of differences in the prevalence of tuberculosis and viral sup-
pression between study groups was calculated using Chi-Square
tests. These statistical analyses were performed using GraphPad
Prism version 6.0c (GraphPad Software, Inc., La Jolla, CA).
Multiple regression analysis was used to assess associations
between clinical and immunological covariates with CD4 T
cell immune activation in a Gaussian generalized linear model
(GLM) with log link function using the statistical software R
(R Development Core Team, 2014) with the R-package glm.
To study the associations among the parameters in this
study a correlationmatrix was plotted applying theR-package
corrplot based on Spearman rank correlations with ordering
of variables following first principal component analysis.
For the analysis of associations between baseline predictors
and treatment outcomes, a model with favorable properties in
regard tomodel complexity and statistical inference is neededdue
to the relatively small sample size in relation to the number of
regarded covariates. Moreover, because of a high degree of cor-
relation between some of the covariates, themodel should be able
to handle a certain level ofmulticollinearity.We therefore used an
unbiased approach for variable selection applying the least ab-
solute shrinkage and selection operator (LASSO) principle on
scaledcovariates.22Subsequently,on thesetofcovariates selected
by LASSO an un-regularized conventional GLM was fitted to
obtain un-shrinked coefficient estimates together with standard
errors. For better comparison of coefficient estimates between the
LASSO and GLM, all covariates have been scaled. Observations
withmissing data for any of the regarded covariates were ignored
and excluded from this analysis. For the regression analysis of the
binary outcome, ‘‘W48 viral suppression’’ a binomial GLMwith
logit link functionwas used. For the continuous outcome ‘‘CD4%
immune recovery’’ a Gaussian GLM with log link function was
chosen. ‘‘Viral suppression’’ was defined as viral load levels be-
low limits of detection at the 48-week study visit. ‘‘Immune re-
covery of CD4%’’ was defined as the difference of CD4% at the
48-week study visit and baseline. The R-packages glm and
glmnet23 were used for these computations.
Sample size determination
There are currently no data describing microbial translo-
cation in severely malnourished children with HIV infection.
However, based on a prior study of sCD14 reduction after
ART initiation in HIV-infected well-nourished children
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living in the United States,24 we calculated that 20 patients
per group will be needed to achieve a power of 80% to detect
a difference in plasma sCD14 of within 1 SD between groups
with a = 0.05. Anticipating potential loss to follow-up, pa-
tients were overenrolled in the HIV-infected groups to ensure
sufficient subjects for the longitudinal part of this study.
Results
Baseline characteristics
Clinical characteristics of each study groups are summarized
in Table 1. Among HIV-infected children, those with SAM
were younger than their counterparts without SAM reflecting
accelerated disease progression in this critically ill population
that results in earlier clinical presentation. Children with SAM,
regardless of HIV status, were stunted with low height for age
z-scores (haz) and showed signs of mixed, that is, chronic and
acute, malnutrition as expressed in low weight for age (waz)
combined with low weight for height z-scores (whz). HIV+-
SAM- children were mildly stunted with low haz scores, but
normal waz and whz scores. Prevalence of active tuberculosis
(TB) disease was higher in malnourished children with 15 cases
out of 32 HIV+SAM+ children and only 5 out of 41 HIV+-
SAM- children at baseline ( p= .0003, Chi-square test). TB
therapy was initiated as per current South African guidelines.
Levels of microbial translocation, intestinal damage,
and monocyte activation differ by HIV- and SAM status
Microbial translocation, as measured by levels of bacterial
16sDNA in plasma, was significantly increased in all groups of
HIV-infected and malnourished children compared to healthy
controls (Fig. 1A). Childrenwith SAMhad higher plasma levels
of iFABP, a marker of intestinal damage, compared to children
without SAM, regardless of HIV status (Fig. 1B). Soluble CD14
(sCD14), a marker of monocyte activation and inflammation,
differed by HIV- but not by SAM status (Fig. 1C).
Malnutrition and HIV infection are associated
with increased immune activation
We investigated T cell activation by measuring CD38 and
HLA-DR expression in CD4+ and CD8+ T cells. Levels of
immune activation in the CD4+ and CD8+ T cell compart-
ment were highest in the HIV-infected study groups, but also
significantly elevated in HIV-uninfected children with SAM
compared to healthy controls (Fig. 1D–F). In regression
analysis SAM (b-coefficient = 0.48, p-value = .0083) and
HIV infection (b-coefficient = 1.04, p-value<.0001) were
independently associated with increased CD4+ T cell acti-
vation controlling for age, sex, and TB status (Supplementary
Table S1). However, there was no significant difference in
CD4+ or CD8+ T cell activation between HIV-infected chil-
dren with or without SAM.
PD1 expression is increased in malnourished
and HIV-infected children
We next hypothesized that higher levels of immune acti-
vation in malnourished and HIV-infected children would be
associated with increased immune exhaustion and studied
PD1 expression, a marker of immune exhaustion.25 PD1
Table 1. Clinical Characteristics of Study Groups Defined by HIV Status and Severe
Acute Malnutrition at Baseline
Baseline characteristics
Characteristics
HIV+ SAM+
(n = 32)
HIV+ SAM-
(n = 41)
HIV- SAM+
(n = 15)
HIV- SAM-
(n = 19)
Age (years) 1.6 (0.7–3.4) 8.2 (4.5–10.7) 0.9 (0.5–1.5) 9.1 (6.8–12.8)
Male sex 18 (56%) 26 (63%) 7 (47%) 9 (47%)
CD4+ T cell count, cells/mm3 541 (149–1167) 412 (212–875) N/A N/A
CD4% 14.9 (8.5–20) 18.0 (9–24.5) N/A N/A
HIV RNA level, copies/ml 1.2 · 106
(5.9 · 105–7.3 · 106)
1.4 · 105
(3.3 · 104–5.9 · 105)
N/A N/A
Active tuberculosis disease 15 (47%) 5 (12%) 0 0
Diarrhea 2 (6%) 2 (5%) 7 (50%) 0
Lower respiratory tract
infection
6 (19%) 3 (7%) 0 0
Oral thrush 5 (16%) 2 (5%) 0 0
WHO stage IV 32 (100%) 8 (20%) N/A N/A
Admitted to hospital 32 (100%) 5 (12%) 15 (100%) 0
Height for age z score (haz) -3.3 (-4.7 to -2.4) -2.0 (-2.8 to -1) -2.1 (-3.6 to -1.2) -0.2 (-1.6 to 1)
Weight for age z score (waz) -3.4 (-4.5 to -3) -0.9 (-1.9 to -0.3) -1.8 (-4 to -1.4) 0.0 (-0.5 to 0.9)
Weight for height z
score (whz)
-1.9 (-3.6 to -0.6) 0.5 (-0.5 to 1.4) -1.2 (-2.4 to 0) 0.9 (0.2–2.3)
Weight for height z
score (whz) <3
11 (34%) 0 1 (7%) 0
Mid-upper arm
circumference <115mm
18 (56%) 0 4 (27%) 0
Bilateral lower extremity
pitting edema
13 (42%) 0 12 (80%) 0
Median values with interquartile range or number of study subjects with percentage are shown for each characteristic by study group.
SAM, severe acute malnutrition; N/A, not applicable.
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surface expression was increased in CD4+ and CD8+ T cells in
all malnourished and HIV-infected study groups (Fig. 2A–C).
Because PD1 expression is commonly higher in T cells
with a more terminally differentiated memory phenotype,26
we also assessed PD1 expression on different memory subsets.
PD1 expression was highest in the CD4+ and CD8+ T effector
memory populations (Tem) and similarly increased in mal-
nourished and HIV-infected children compared to healthy
controls (Fig. 2D, E). Of note, while PD1 expression differed
by SAM status in HIV-uninfected children, there was no sig-
nificant difference by SAM status in HIV-infected children.
Markers of microbial translocation, immune activation,
and immune exhaustion correlate with each other
and clinical markers of disease progression
To better understand the nature of the associations between
the immunological and clinical parameters in this study, we
constructed a correlation matrix using data from all 107
participants at baseline. Variables were grouped based on
principal component analysis, and results were visualized
using the R package ‘‘corrplot’’ (Fig. 3). Parameters of im-
mune activation, immune exhaustion, microbial transloca-
tion, and viral load are associated with disease cluster
together based on strong positive correlations and are op-
posed to the second cluster of clinical parameters associated
with health (i.e., high CD4% and anthropometric measure-
ments) based on negative correlations. A similar pattern was
observed, including only HIV-positive children (n = 73) in
the analysis (Supplementary Fig. S2).
SAM is associated with higher mortality in HIV-infected
children starting ART
All HIV-infected children were initiated on ART accord-
ing to the current South African guidelines. During the 48-
week follow-up period, 5 of 32 children in the HIV+SAM+
group and 1 of 41 children in the HIV+SAM- group were
deceased (Fig. 4A). The median time from enrollment to
death was 31 days (range 9–131 days). Causes of death in the
HIV+SAM+ children were bacterial infections with sepsis (3),
pneumonia (1), gastroenteritis (1), and TB-meningitis in the
HIV+SAM- child. The higher mortality rate of children with
SAMwas statistically significant ( p= .047, log-rank (Mantel–
Cox) test) and independent of active TB disease. Excluding all
TB cases from the analysis, 3 out of 17 children in the
HIV+SAM+ group died compared to 0 out of 36 children in the
HIV+SAM- group ( p= .0171, log-rank (Mantel–Cox) test)
(Fig. 4B). Four HIV+SAM- children (9.8%) and 1 HIV+
SAM+ child (3.1%) were lost to follow-up.
Malnutrition, microbial translocation, and immune
activation are associated with detrimental treatment
outcomes in children initiating ART
For the 48 HIV-infected children who completed the
follow-up period with available data for all parameters at
FIG. 1. Plasma biomarkers and immune activation by study group at baseline. (A–C) Plasma levels of 16sDNA (A),
iFABP (B), and sCD14 (C) in children stratified by HIV status and presence of SAM at baseline. Open symbols indicate
active tuberculosis disease; red symbols indicate children that passed away during the study period. Medians are shown as
horizontal bars. (D) Representative CD4+ T cell immune activation FACS data from an HIV-positive child with severe
acute malnutrition (HIV+SAM+, left) and a healthy control (HIV-SAM-, right). (E, F) Activation of CD4+ and CD8+ T
cells in children stratified by HIV status and nutritional state. Kruskal–Wallis ANOVA with Dunn’s correction for multiple
comparisons was used to determine statistical significance (*p < .05; **p < .01; ***p < .001; ****p < .0001). iFABP, in-
testinal fatty acid-binding protein; SAM, severe acute malnutrition.
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baseline, we first assessed which variables were associated
with viral suppression at week 48. Because of the fairly large
number of covariates compared to the relatively low number of
cases studied here, we used the LASSO approach for variable
selection.We then included these selected predictor variables in
a GLM for confirmation. Active TB disease and high levels of
sCD14 and 16sDNA at baseline were independently associated
negatively with viral suppression at W48 (Table 2). Of note,
therewas no statistically significant difference for the proportion
of children with viral suppression at week 48 between the two
groups (11 of 18 HIV+SAM+ children and 21 of 30 HIV+
SAM- children; p= .53, Chi-square test).
Subsequently we investigated the relationship of the clin-
ical and immunological parameters at baseline with the rate
of immune reconstitution as measured by recovery of CD4%
in children with viral suppression at the week 48 study visit.
We in this study defined the rate of CD4% recovery, that is,
the difference of CD4% between the week 48 study visit and
baseline, as the dependent variable. For this analysis we only
included the 32 children with viral suppression at the week 48
visit and with complete data for all parameters at baseline.
Out of the set of 14 predictor variables, 8 variables were
selected by the LASSO approach that was included in our
final GLM. SAM, sCD14, 16sDNA, CD4%, and CD8+ T cell
activation at baseline were associated with lower rates of
immune recovery at a statistically significant level in the
confirmatory GLM (Table 2). These results demonstrate an
association of SAM, increased microbial translocation, and
systemic immune activation with impaired CD4% recovery
in children initiated on ART.
Discussion
While microbial translocation, immune activation, and
immune exhaustion have been identified as key drivers in the
pathogenesis of HIV disease, their role inmalnutrition remains
unclear. HIV-infected children with SAM likely represent a
distinct clinical entity with a severe disease phenotype27 given
that these children tend to present at a young age with in-
creased comorbidities and high mortality. In this study, we
show that SAM is associated with increased microbial trans-
location, immune activation, and immune exhaustion in HIV-
uninfected children and with an impaired response to ART in
HIV-infected children.
FIG. 2. PD1 expression by study group. (A) CD8+ T cell PD1 FACS data showing an FMO control (top) and a
representative HIV+SAM+ sample (bottom). (B, C) PD1 expression in CD4+ and CD8+ T cells by study group. Open symbols
indicate active TB disease; red symbols indicate children that passed away during the study period. (D, E) PD1 expression on
CD4 and CD8 T cell memory subsets defined by CD45RA and CCR7 expression (Tn: CD45RA+CCR7+, Tcm:
CD45RA-CCR7+, Tem: CD45RA-CCR7-, Temra: CD45RA+CCR7-). Kruskal–Wallis ANOVA with Dunn’s correction for
multiple comparisons was used to determine statistical significance (*p< .05; **p< .01; ***p< .001; ****p< .0001).
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In our study, microbial translocation was not only in-
creased in HIV-infected children as previously reported28,29
but also in HIV-uninfected malnourished children. Child-
hood malnutrition leads to alterations of the intestinal mi-
crobiome, chronic gut inflammation, and structural changes
in the epithelium resulting in enteropathy with loss of intes-
tinal barrier functions.7 We in this study show that plasma
levels of iFABP, which is released by dying epithelial cells
and used as a plasma marker of intestinal damage,30 were
elevated in malnourished children independent of HIV status
indicating structural intestinal damage that predisposes to
microbial translocation.
Translocation of luminal bacterial products into the sys-
temic circulation triggers systemic immune activation.13 In
pediatric HIV infection, chronic T cell activation is a key
component of systemic immune activation and plays a central
role in HIV pathogenesis.14,21 Consistent with previous re-
ports28 we observed increased levels of T cell activation in
HIV-infected children that correlated with markers of disease
progression, microbial translocation, and monocyte activa-
tion. Earlier studies of malnourished children without ap-
parent infections reported activation of the innate immune
system with elevated leukocyte counts and increased acute
phase responses.7 We in this study show that T cell immune
activation is also increased in HIV-uninfected malnourished
children and confirmed an independent effect of SAM on
CD4+ T cell activation controlling for HIV infection, age,
sex, and TB status in a multivariate analysis. These data
show that increased T cell immune activation forms part of
the complex immunological alterations in malnutrition.
FIG. 3. Associations between plasma biomarkers and immunological and clinical variables. (A) Correlation matrix with
available data from all participants at baseline (n= 107). Positive correlations are indicated in blue, and inverse correlations
are indicated in red. Darker color shades indicate higher r-values. In the lower panel r- and p-values are indicated based on
Spearman’s rank correlation tests (*p < .05; **p < .01; ***p < .001; ****p < .0001). Clustering of variables is based on
principal component analysis using the R package corrplot and reveals two well-differentiated groups of parameters, one
associated with disease (upper left quadrant) and the other associated with health (lower right quadrant). (B) Selected
bivariate associations with Spearman rank correlation tests.
FIG. 4. Increased mortality
in malnourished HIV-infected
children on ART. (A) Kaplan–
Meier curves comparing sur-
vival between all HIV-infected
childrenwithandwithoutSAM.
(B) Kaplan–Meier survival
curves excluding all TBcases.
Log-rank (Mantel–Cox) tests
were applied for statistical com-
parison between the groups.
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However, we observed similar levels of immune activation in
HIV-infected children with SAM compared to HIV-infected
children with normal nutritional status indicating no further
increase in immune activation due to malnutrition in HIV
infection. Although we observed higher levels of iFABP in
malnourished children regardless of HIV status indicative of
more intestinal damage in these groups, this did not seem to
result in higher levels of microbial translocation or immune
activation in the HIV+SAM+ group possibly indicating that
the high levels of immune activation and inflammation in
HIV-infected children are not significantly modulated further
by malnutrition.
Studies of lymphocyte function in malnourished children
consistently showed deficits in cellular immunity such as
reduced proliferative responses to PHA stimulation31 and
impaired cytokine production upon in vitro stimulation.32–35
These functional deficits resemble the effects of immune
exhaustion on T cell function as previously described in
studies of chronic viral infections (LCMV, HIV) and can-
cer.36 We therefore hypothesized that the alterations in T cell
function observed in malnourished children are associated
with immune exhaustion and measured expression levels of
PD1, a marker of immune exhaustion.25,37 PD1 expression on
T cells was increased in malnourished HIV-uninfected chil-
dren to levels similar to HIV-infected children. PD1 levels
strongly correlated with T cell activation at baseline suggest-
ing that immune exhaustion is driven by immune activation as
previously hypothesized.38,39 Of note, PD1 expression did not
differ by SAM status in HIV-infected children analogous to
our observations for immune activation.
In the prospective part of this study we assessed the potential
role of malnutrition, microbial translocation, and immune ac-
tivation to predict treatment outcomes in HIV-positive children
initiated on ART. Consistent with previous reports,4,5 SAM at
baseline was highly predictive of all-causemortality in children
on ART. Monocyte activation, microbial translocation, and
active TB disease were independently correlated inversely with
viral suppression at 48 weeks of ART. Monocyte activation,
microbial translocation, malnutrition, age, and CD8+ T cell
activation at baseline were independently associated with im-
paired immune recovery. Of note, while our analysis did show
a negative association between SAM and immune recovery,
other markers such as CD4%, sCD14, and CD8 T cell activa-
tion at baseline seemed to be of more predictive value for
immune recovery. These findings are consistent with previous
studies in HIV-infected adults that found high levels of PD-1
expression,40-42 T cell activation43 and microbial transloca-
tion44,45 to be associated with poor immune recovery.
Our study has a number of important limitations. First,
there are profound differences between the study groups,
including younger age and increased comorbidities in the
children with SAM reflecting the severe disease phenotype in
this critically ill population. The observed differences be-
tween the groups should therefore not solely be attributed
to malnutrition per se, but malnutrition should rather be re-
garded as an important indicator of severe illness that is as-
sociated with profound immunological alterations. Second,
in the prospective part of the study the number of participants
with complete available data was relatively low and hence we
only followed an exploratory hypothesis building approach in
Table 2. Association of Clinical and Immunological Predictors with Treatment Outcomes
Predictors associated with HIV treatment outcomes
Co-variable
W48 viral suppression
Co-variable
CD4% immune recovery
LASSO GLM LASSO GLM
b-coefficient b-coefficient p-value b-coefficient b-coefficient p-value
Active TB -0.67 -1.30 0.005 sCD14 -1.38 -3.10 0.026
sCD14 -0.74 -1.47 0.006 16sDNA -3.26 -4.32 0.002
16sDNA -0.50 -1.37 0.025 SAM -0.99 -4.07 0.019
SAM 0 — — Age -1.84 -3.43 0.037
Age 0 — — CD8 activation -2.74 -4.16 0.012
CD8 activation 0 — — CD4% -5.48 -7.17 <0.0001
CD4% 0 — — iFABP 0.49 0.7435 0.61
iFABP 0 — — CD4 activation 0.38 1.63 0.30
CD4 activation 0 — — Active TB 0 — —
Viral load 0 — — Viral load 0 — —
Sex (male) 0 — — Sex (male) 0 — —
CD4 count 0 — — CD4 count 0 — —
CD4 PD1 0 — — CD4 PD1 0 — —
CD8 PD1 0 — — CD8 PD1 0 — —
CD4 T naive 0 — — CD4 T naive 0 — —
In the left panel, results are shown for analysis of the clinical outcome ‘‘W48 viral suppression’’ (i.e., viral load below detectable limits at the
48-week study visit) for all HIV-infected children with complete follow-up and available data for all parameters at baseline (n= 48). LASSO
selected three predictor variables, ‘‘active TB (tuberculosis) disease’’, ‘‘sCD14,’’ and 16sDNA at baseline, to be negatively associated with
successful viral suppression out of a set of 14 predictor variables. These three predictor variables were included in a generalized linear model
(GLM) for confirmation. In the right panel, results are shown for analysis of recovery of CD4% from baseline at week 48, that is, the difference
between CD4% at the week 48 study visit and baseline. For this analysis, only children with viral suppression at the W48 study visit were
included (n= 32). LASSO selected eight predictors of which ‘‘sCD14,’’ ‘‘16sDNA,’’ ‘‘SAM’’ (severe acute malnutrition), ‘‘Age,’’ ‘‘CD8 T cell
activation,’’ and ‘‘CD4% at baseline’’ could be confirmed in a generalized linear model to be negatively associated with immune recovery at a
statistically significant level. For better comparison of beta-coefficients, scaled data were used for all models.
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our analysis. These results should be validated in larger co-
horts of malnourished HIV-infected children. Although we
did not detect statistically significant differences between the
sexes in our analyses likely due to the relatively low num-
ber of cases, future studies on microbial translocation—
especially in the context of HIV—should take sex into account
since sexual dimorphisms have previously been reported for
both conditions.4,46,47 Finally, due to the observational char-
acter of this study we can only describe associations.
In summary, we demonstrate that SAM is an indicator of
severe disease that is associated with worse prognosis and
impaired immune recovery in HIV-infected children on ART
prompting extensive medical attention for this population.
Immune activation and microbial translocation are associated
with impaired immune recovery in HIV-infected children
initiated on ART and represent viable targets for additional
interventions.
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